Acute & Delayed Phase CINV
- 2022 CPG – Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2017 CPG – Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Endorsed by the Children’s Oncology Group (COG)
- Archived 2013 CPG – Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of our processes, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines
Related Articles
Bruce Power and supplier partners donate $100,000 to Pediatric Oncology Group of Ontario
Originally published on the Bruce Power website, September 25, 2024
Antibacterial ProphylaxisAntifungal ProphylaxisChemotherapy-Induced Nausea & VomitingAcute delayed Phase CINVAnticipatory CINVBreakthrough & Refractory CINVEmetogenicity ClassificationAcute & Delayed Phase CINVChronic Pain*Clostridium Difficile InfectionFatigueFertility Preservation*MucositisOtotoxicityFever and NeutropeniaPlatelet Transfusion*Venous Thromboembolism*
Care Pathways
YOU can be a champion for kids with cancer!
With your help, we will ensure that kids and youth with cancer, their families and survivors of childhood cancer have equitable access to the best care for the best possible outcomes.